Table 1 –
Study design | |
---|---|
External validation of a previously developed model | 14 (28%) |
New model with internal validation | 36 (72%) |
Study outcome | |
Disease detection | 30 (60%) |
Survival | 15 (30%) |
Functional recovery | 1 (2.0%) |
Disease recurrence | 4 (8.0%) |
Field of investigation | |
Cancer | 31 (62%) |
Cardiovascular diseases | 6 (12%) |
Other | 13 (26%) |